- Home
- HTH vs IDYA Comparison
HTH vs IDYA Comparison
Compare HTH & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTH
- IDYA
- Stock Information
- Founded
- HTH 1998
- IDYA 2015
- Country
- HTH United States
- IDYA United States
- Employees
- HTH N/A
- IDYA N/A
- Industry
- HTH Major Banks
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- HTH Finance
- IDYA Health Care
- Exchange
- HTH Nasdaq
- IDYA Nasdaq
- Market Cap
- HTH 2.1B
- IDYA 2.3B
- IPO Year
- HTH 2004
- IDYA 2019
- Fundamental
- Price
- HTH $32.73
- IDYA $26.96
- Analyst Decision
- HTH Hold
- IDYA Buy
- Analyst Count
- HTH 1
- IDYA 15
- Target Price
- HTH $32.00
- IDYA $47.92
- AVG Volume (30 Days)
- HTH 319.1K
- IDYA 1.2M
- Earning Date
- HTH 10-23-2025
- IDYA 11-03-2025
- Dividend Yield
- HTH 2.20%
- IDYA N/A
- EPS Growth
- HTH 27.10
- IDYA N/A
- EPS
- HTH 2.22
- IDYA N/A
- Revenue
- HTH $1,233,449,000.00
- IDYA $7,000,000.00
- Revenue This Year
- HTH N/A
- IDYA $63.41
- Revenue Next Year
- HTH $0.66
- IDYA $305.49
- P/E Ratio
- HTH $14.76
- IDYA N/A
- Revenue Growth
- HTH 4.92
- IDYA N/A
- 52 Week Low
- HTH $26.67
- IDYA $13.45
- 52 Week High
- HTH $36.14
- IDYA $32.67
- Technical
- Relative Strength Index (RSI)
- HTH 37.91
- IDYA 58.57
- Support Level
- HTH $32.61
- IDYA $26.88
- Resistance Level
- HTH $33.62
- IDYA $28.41
- Average True Range (ATR)
- HTH 0.66
- IDYA 1.01
- MACD
- HTH -0.22
- IDYA 0.08
- Stochastic Oscillator
- HTH 2.96
- IDYA 58.38
About HTH Hilltop Holdings Inc.
Hilltop Holdings Inc is a Dallas-based financial holding company. The Company has two primary business units, PCC (banking and mortgage origination) and Securities Holdings (broker-dealer). The banking segment includes the operations of the Bank. The banking segment provides business and consumer banking services from offices located throughout Texas and generates revenue from its portfolio of earning assets. The broker-dealer segment includes the operations of Securities Holdings, which operates through its wholly owned subsidiaries Hilltop Securities, Asset Managment LLC, etc. The broker-dealer segment generates a majority of its revenues from fees and commissions earned from investment advisory and securities brokerage services. Majority of revenue is from Banking Segment.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.